Clinerion protects Patient Network Explorer user accounts with 2-step authentication.
The “Clinerion PNEx Authenticator” app gives users of Clinerion’s Patient Network Explorer additional data security with 2-step authentication.
To protect Patient Network Explorer user accounts from breach, Clinerion is activating a second verification step during the sign-in process. In addition to the password, Patient Network Explorer now includes an authorization step that will run via the “Clinerion PNEx Authenticator” smartphone app.
In this new step when logging in to a Patient Network Explorer account, the app will prompt the user to confirm their identity using their smartphone’s own authentication system, e.g., PIN code, fingerprint, or facial recognition.
“As a data services company, we know more than anyone else the importance of keeping user account data safe,” says Andreas Walter, Chief Technology Officer of Clinerion. “We are committed to defending the security of our users and protecting their account data.”
Clinerion accelerates clinical research and medical access to treatments for patients. We generate real-world data from our global network of partner hospitals for Real World Evidence analyses. Clinerion’s Patient Network Explorer radically improves the efficiency and effectiveness of clinical trial recruitment by offering data-driven protocol optimization, site feasibility evaluation and real-time patient search and identification to match patients to treatments.
Clinerion facilitates the participation of partner hospitals in leading-edge, industry-sponsored trials and time savings in patient recruitment. Researchers gain access to real-time, longitudinal patient data from electronic health records for analysis. We enable pharmaceutical companies, CROs and SMOs to shorten patient recruitment and save costs by streamlining operations and leveraging strategic intelligence. Clinerion’s Patient Network Explorer also provides a platform for integration of diverse patient data sources into real-world data ecosystems. Clinerion’s proprietary technologies comply with international patient privacy and data security regulations. It is a global data technology service company headquartered in Switzerland.